Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fabrazyme in Fabry Disease
NCT00074984Phase 4Completed
- Sponsor
- Sanofi
- Start
- Feb 2001
- Primary completion
- Jan 2004
- Modality
- Replacement Enzymes
- Countries
- 6
01
Overview
Phase 4, randomised, double-blind trial in Fabry disease (FD) comparing Fabrazyme with Placebo (2 arms). Primary endpoint: Number of Participants Experiencing a Clinically Significant Renal, Cardiac or Cerebrovascular Event and/or Death at 35 months. Started Feb 2001; status: completed.
02
Drugs
agalsidase beta
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT00074984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00074984.